• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “tdf-ventures” Archives

          in
          Entry Author Date Location
          NASA, Liongard, Springdale, TFF, HX, [email protected] & More TX Tech Angela Shah 06/04/19 Texas
          Vlocity Lands $50,000,000 New Financing Round VentureDeal 09/21/16 San Francisco
          Valencell Secures $11,000,000 Series D Funding VentureDeal 03/09/16 Raleigh Durham
          Valencell Raises $11M to Support Wearable Tech R&D Frank Vinluan 03/08/16 Raleigh Durham
          OpsPanda Obtains $5,000,000 Series A Round VentureDeal 02/11/16 San Francisco
          Stellar Loyalty Obtains $4,000,000 Series A Funding VentureDeal 02/09/16 San Francisco
          Valencell Sues Apple, Fitbit, Claims Wearable Sensor Tech Infringed Frank Vinluan 01/05/16 Raleigh Durham
          Cloverpop Secures $1,800,000 Seed Financing VentureDeal 10/07/15 San Francisco
          AppMesh Obtains $3,000,000 New Financing Round VentureDeal 09/04/13 San Francisco
          Outbox Garners $5,000,000 Series A Funding VentureDeal 07/02/13 Texas
          Booker Lines Up $27.5M in Series B Round Led by Bain Capital Ventures João-Pierre S. Ruth 04/16/13 New York
          Booker Receives $27,500,000 Series B Round VentureDeal 04/16/13 New York
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • How to Approach Life Sciences Fundraising

            Sponsored · Whitepaper

            How to Approach Life Sciences Fundraising

            Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research

            Brex
          • Decentralized Clinical Trials: The Call for a New Paradigm

            Sponsored · Whitepaper

            Decentralized Clinical Trials: The Call for a New Paradigm

            Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications

            PRA Health Sciences
          • The Bay Area and Beyond: Biocom Talks Innovation and COVID

            Sponsored · Video

            The Bay Area and Beyond: Biocom Talks Innovation and COVID

            A Fireside Chat with Biocom President & CEO Joe Panetta

            Biocom

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.